These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3481507)

  • 81. CA-125 monitoring during chemotherapy for ovarian cancer.
    Martoni A; Bellucco A; Marabini A; Orlandi C; Platé L; Bianchi D; Pannuti F
    Int J Biol Markers; 1986; 1(3):121-8. PubMed ID: 3480916
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Isolated splenic metastases of cancer of the ovary].
    Cleophax JP; Pujade-Lauraine E
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(8):995-8. PubMed ID: 2081877
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Studies on xenogenic antisera to tumor-associated antigen of ovarian carcinoma.
    Gerber MA; Faiferman I; Cohen CJ; Koffler D
    Clin Immunol Immunopathol; 1977 Sep; 8(2):171-80. PubMed ID: 198173
    [No Abstract]   [Full Text] [Related]  

  • 84. Autologous antibodies eluted from membrane fragments in human ovarian epithelial neoplastic effusions. III. Cytotoxic potential in vitro and characterization of antigen(s).
    Kutteh WH; Baker VV; Doellgast GJ
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1301-6. PubMed ID: 2220942
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cell-mediated immunity to human malignant cells. A brief review and further studies with two gynecologic tumors.
    DiSaia PJ; Sinkovics JG; Rutledge FN; Smith JP
    Am J Obstet Gynecol; 1972 Dec; 114(7):979-89. PubMed ID: 4118903
    [No Abstract]   [Full Text] [Related]  

  • 86. Cellular DNA content and CA-125 antigen expression in ovarian carcinomas.
    Baker VV; Haskill S; Fowler WC; Walton LA; Currie JL
    Oncology; 1987; 44(5):283-6. PubMed ID: 3478626
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Leukocyte migration in ovarian carcinoma: comparison of inhibitory activity of tumor extracts.
    Faiferman I; Gleicher N; Cohen CJ; Koffler D
    J Natl Cancer Inst; 1977 Dec; 59(6):1593-7. PubMed ID: 200754
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Assessment of serum CA 19.9 as a tumour marker in patients with carcinoma of the bladder and prostate.
    Abel PD; Cornell C; Buamah PK; Williams G
    Br J Urol; 1987 May; 59(5):427-9. PubMed ID: 3474046
    [TBL] [Abstract][Full Text] [Related]  

  • 89. An unusual evolution of the serum CA 125 level in a ovarian cancer patient.
    Huys J; Vereecke C; De Sutter L; Troch M
    Gynecol Oncol; 1993 May; 49(2):259-61. PubMed ID: 8504997
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Transforming growth factor-beta and ovarian carcinoma cells: regulation of proliferation and surface antigen expression.
    Marth C; Lang T; Koza A; Mayer I; Daxenbichler G
    Cancer Lett; 1990 Jun; 51(3):221-5. PubMed ID: 2112423
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Quantitation of antigens in normal and malignant ovarian tissue.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1975 Oct; 123(3):302-4. PubMed ID: 1180293
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The value of CA 125 serum assay in the management of ovarian cancer.
    Lambert J
    Br J Obstet Gynaecol; 1987 Mar; 94(3):193-5. PubMed ID: 3471272
    [No Abstract]   [Full Text] [Related]  

  • 93. [CA 19-9 and CA 125 in hepatobiliary pathology].
    Preux C; Gerard M; Delhange A; Bondue H; Delcourt A
    Acta Gastroenterol Belg; 1987; 50(1):45-51. PubMed ID: 3480670
    [No Abstract]   [Full Text] [Related]  

  • 94. Immunoelectronmicroscopic demonstration of surface tumor antigen Ca 125.
    Blaustein A
    Ultrastruct Pathol; 1984; 7(1):9-11. PubMed ID: 6595865
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Tumor-associated carbohydrate antigens.
    Dabelsteen E; Clausen H
    J Oral Pathol; 1987 Apr; 16(4):196-8. PubMed ID: 3114459
    [No Abstract]   [Full Text] [Related]  

  • 96. Prospects and applications of monoclonal antibodies in gynecological oncology.
    Kenemans P; Verheijen RH; Leloux AM; Poels LG
    Eur J Obstet Gynecol Reprod Biol; 1985 Jun; 19(6):340-6. PubMed ID: 3894103
    [No Abstract]   [Full Text] [Related]  

  • 97. The structure of the Ca-antigen.
    Wiseman G; Bramwell ME; Bhavanandan VP; Harris H
    Biochem Soc Trans; 1984 Jun; 12(3):537-8. PubMed ID: 6588010
    [No Abstract]   [Full Text] [Related]  

  • 98. Detection of intracellular/intranuclear antigens in tumor cells.
    Widen RH; Becker JL
    Methods Mol Biol; 1998; 91():57-65. PubMed ID: 9664481
    [No Abstract]   [Full Text] [Related]  

  • 99. [Effect of biliary tract obstruction and cholangitis on serum CA 19-9 levels].
    Okaga M; Karasawa H; Kobayashi T; Satsukime N; Miki R
    Nihon Shokakibyo Gakkai Zasshi; 1985 May; 82(5):1418. PubMed ID: 3861895
    [No Abstract]   [Full Text] [Related]  

  • 100. Screening for ovarian cancer by CA-125 measurement.
    Jacobs I
    Lancet; 1988 Apr; 1(8590):889. PubMed ID: 2895400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.